Evidence map›Paper›PMID 9135543›Full record

ArticleImmunology1997

Mutations affecting the superantigen activity of staphylococcal enterotoxin B.

C Briggs, C Garcia, L Zhang, L Guan, J L Gabriel, T J Rogers

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

C BriggsDepartment of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
C Garcia
L Zhang
L Guan
J L Gabriel
T J Rogers
Temple University · US

Funding

IMMUNOSUPPRESSIVE ACTION OF STAPHYLOCOCCAL ENTEROTOXINSR01AI023828 · NIAID · TEMPLE UNIVERSITY · PI ROGERS, THOMAS J · 1987 to 1996
–
NIAID NIH HHS AI23828
6 · The paper itself

Abstract

As a superantigen, staphylococcal enterotoxin B (SEB) possesses the ability to bind to major histocompatibility complex class II molecules and be recognized by T cells bearing certain T-cell receptor (TCR) V beta alleles. Other investigators have utilized site-specific mutagenesis to generate amino acid substitutions to identify residues that may be involved in the interaction with the TCR beta-chain. In an attempt further to define the face of the SEB molecule involved in the interaction with the beta-chain, we have employed a polymerase chain reaction (PCR)-based, site-specific mutagenesis method to generate amino acid substitutions with altered superantigen activity. Our results show that valine at position 169 appears to be involved in the function of this superantigen, since each of several substitutions at this position exhibit a significantly reduced ability to induce T-cell proliferation. Analysis of the responding T cells to the residue 169 substitution shows that the mutant toxins maintain TCR V beta selectivity. At the same time, mutation of the proximal histidine at position 166 does not alter the superantigen activity of SEB. Radiolabelled binding analysis of these H166 and V169 mutants shows that class II-binding activity is not significantly altered. When viewed in the context of other results reported in the literature, combined with the crystal structure of the toxin, our results suggest that the interaction with the TCR probably involves SEB residues which ring a cavity along one side of the toxin molecule.

Indexed as

AnimalsCell DivisionEnterotoxinsHLA-DR1 AntigenMiceMice, Inbred BALB CMice, Inbred C3HMutagenesis, Site-DirectedPolymerase Chain ReactionReceptors, Antigen, T-Cell, alpha-betaRecombinant ProteinsStructure-Activity RelationshipSuperantigensT-Lymphocytesenterotoxin B, staphylococcalEnterotoxinsHLA-DR1 AntigenReceptors, Antigen, T-Cell, alpha-betaRecombinant ProteinsSuperantigens

Identifiers

PMID9135543
PMCPMC1456745
OpenAlexW2019806222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.